A detailed history of Golden Road Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Golden Road Advisors LLC holds 351 shares of LLY stock, worth $269,483. This represents 0.24% of its overall portfolio holdings.

Number of Shares
351
Previous 352 0.28%
Holding current value
$269,483
Previous $328 Million 5.26%
% of portfolio
0.24%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $772 - $960
-1 Reduced 0.28%
351 $311 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 2.92%
352 $328 Million
Q1 2024

Apr 18, 2024

SELL
$592.2 - $792.28 $6,514 - $8,715
-11 Reduced 3.12%
342 $266 Million
Q4 2023

Mar 14, 2024

BUY
$525.19 - $619.13 $185,392 - $218,552
353 New
353 $206 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Golden Road Advisors LLC Portfolio

Follow Golden Road Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden Road Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden Road Advisors LLC with notifications on news.